(CL) Colgate-Palmolive - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1941621039
CL EPS (Earnings per Share)
CL Revenue
CL: Oral Care, Personal Care, Home Care, Pet Nutrition
Colgate-Palmolive Company is a multinational consumer products company with a diverse portfolio of brands across oral, personal, and home care, as well as pet nutrition. The companys Oral, Personal and Home Care segment is a leader in the global market, offering a wide range of products, including toothpaste, toothbrushes, and soap, under well-known brands such as Colgate, Palmolive, and Irish Spring. Additionally, the company has a strong presence in the pet nutrition market through its Hills Science Diet and Hills Prescription Diet brands, catering to the nutritional needs of dogs and cats.
The companys product portfolio is marketed and sold through various channels, including traditional retailers, eCommerce platforms, wholesalers, and distributors, as well as directly to dentists and skin health professionals. With a history dating back to 1806, Colgate-Palmolive Company has established itself as a trusted and reliable brand, with a global presence and a commitment to delivering high-quality products that meet the evolving needs of consumers.
From a technical analysis perspective, the stock has been trading within a relatively stable range, with its 20-day and 50-day simple moving averages (SMA20 and SMA50) indicating a slight upward trend. The average true range (ATR) suggests a moderate level of volatility, with a 2% daily price movement. Considering the current price is near its SMA20 and SMA50, and below its SMA200, we can anticipate a potential breakout or a consolidation phase.
Based on the fundamental data, Colgate-Palmolive Company has a market capitalization of approximately $73.7 billion, with a price-to-earnings (P/E) ratio of 25.75 and a forward P/E ratio of 24.81. These metrics indicate a relatively stable valuation, considering the companys stable cash flows and dividend payments. By combining the technical and fundamental analysis, we can forecast that the stock may experience a moderate increase in the short term, driven by its stable fundamentals and potential breakout from its current trading range. A potential target price could be around $95-$100, representing a 2-3% increase from its current price.
Taking into account the companys diversified portfolio, global presence, and commitment to innovation, we can expect Colgate-Palmolive Company to continue delivering stable returns to its shareholders. The pet nutrition segment is expected to drive growth, driven by increasing demand for premium pet food products. As the company continues to expand its eCommerce presence and invest in digital marketing, we can anticipate further upside potential in the stock price.
Additional Sources for CL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CL Stock Overview
Market Cap in USD | 73,100m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Household Products |
IPO / Inception | 1977-01-03 |
CL Stock Ratings
Growth Rating | 23.6 |
Fundamental | 63.1 |
Dividend Rating | 57.6 |
Rel. Strength | -13 |
Analysts | 3.77 of 5 |
Fair Price Momentum | 88.22 USD |
Fair Price DCF | 91.78 USD |
CL Dividends
Dividend Yield 12m | 2.21% |
Yield on Cost 5y | 3.11% |
Annual Growth 5y | 2.50% |
Payout Consistency | 99.6% |
Payout Ratio | 55.5% |
CL Growth Ratios
Growth Correlation 3m | -0.7% |
Growth Correlation 12m | -65.3% |
Growth Correlation 5y | 66.5% |
CAGR 5y | 6.82% |
CAGR/Max DD 5y | 0.33 |
Sharpe Ratio 12m | 0.27 |
Alpha | -7.75 |
Beta | 0.117 |
Volatility | 18.22% |
Current Volume | 5332k |
Average Volume 20d | 4747.3k |
As of June 16, 2025, the stock is trading at USD 90.26 with a total of 5,331,994 shares traded.
Over the past week, the price has changed by -0.67%, over one month by +0.70%, over three months by +0.06% and over the past year by -3.90%.
Yes, based on ValueRay´s Fundamental Analyses, Colgate-Palmolive (NYSE:CL) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 63.08 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CL is around 88.22 USD . This means that CL is currently overvalued and has a potential downside of -2.26%.
Colgate-Palmolive has received a consensus analysts rating of 3.77. Therefor, it is recommend to hold CL.
- Strong Buy: 7
- Buy: 6
- Hold: 7
- Sell: 1
- Strong Sell: 1
According to our own proprietary Forecast Model, CL Colgate-Palmolive will be worth about 95.3 in June 2026. The stock is currently trading at 90.26. This means that the stock has a potential upside of +5.56%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 98.3 | 8.9% |
Analysts Target Price | 98.8 | 9.5% |
ValueRay Target Price | 95.3 | 5.6% |